Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)

Treatment for Subjects With Active Rheumatoid Arthritis (RA)

NCT00110903 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating the Efficacy and Safety of Etanercept

NCT00546533 ·Status: COMPLETED ·Phase: PHASE4

Etanercept SFP in RA Patients

NCT00413452 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis

NCT00484237 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab

NCT01927757 ·Status: TERMINATED ·Phase: PHASE4

Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

NCT01557322 ·Status: COMPLETED

Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis

NCT00195494 ·Status: COMPLETED ·Phase: PHASE4

Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA

NCT00418717 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis

NCT00418548 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects

NCT00252668 ·Status: COMPLETED ·Phase: PHASE4

Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission

NCT02373813 ·Status: COMPLETED ·Phase: PHASE3

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)

NCT02115750 ·Status: COMPLETED ·Phase: PHASE3

A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

NCT00520572 ·Status: COMPLETED ·Phase: PHASE2

Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate

NCT01783015 ·Status: TERMINATED ·Phase: PHASE4

Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials

NCT00357903 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region

NCT00422227 ·Status: COMPLETED ·Phase: PHASE4

Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

NCT00848354 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

NCT02986139 ·Status: COMPLETED ·Phase: PHASE3

Very Early Versus Delayed Etanercept in Patients With RA

NCT02433184 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept

NCT01901185 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan

NCT00688103 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry

NCT01646385 ·Status: COMPLETED

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

NCT00962741 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)

NCT00099554 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

NCT00293722 ·Status: COMPLETED